Omnicell, Inc. (OMCL)Healthcare | Health Information Services | Fort Worth, United States | NasdaqGS
35.78 USD
+0.39
(1.088%)
⇧
(Oct. 15, 2026, 11:43 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 9:59 a.m. EDT
The investment case for Omnicell is currently broken by a severe disconnect between its historical performance and its recent operational reality. While the company boasts a massive analyst target price of $57.85, implying a 60% upside, the actual price trajectory tells a different story: the stock has suffered four consecutive years of negative annual returns, dragging the total return over the last nine years down to nearly -20%. This multi-year decline is the market's verdict that the business quality has deteriorated, rendering the low forward P/E a value trap rather than a bargain. The lack of any dividend payout eliminates the income floor for investors, leaving them entirely exposed to capital appreciation that the recent trend suggests is unlikely. Although the recent price action shows a slight bounce off the lows, the heavy put option positioning confirms that speculative capital is betting on continued weakness, making this a high-risk environment where the 'strong buy' analyst consensus appears disconnected from the harsher reality of the share price. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.072456 |
| AutoETS | 0.072464 |
| AutoTheta | 0.076682 |
| MSTL | 0.082855 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 24.89 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.168 |
| Excess Kurtosis | -1.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 15.484 |
| Revenue per Share | 27.489 |
| Market Cap | 1,631,872,512 |
| Trailing P/E | 43.63 |
| Forward P/E | 17.41 |
| Beta | 0.99 |
| Profit Margins | 3.14% |
| Website | https://www.omnicell.com |
As of Oct. 10, 2026, 9:59 a.m. EDT: Speculators are positioning for significant downside protection rather than upside participation. Put open interest is heavily concentrated at strikes well below the current price (17.5 and 30), indicating a 'floor' expectation. Conversely, call open interest is skewed toward distant strikes (50, 60) with very low volume, suggesting limited belief in a near-term recovery. The implied volatility surface shows elevated premiums for deep out-of-the-money puts compared to calls, reflecting a market pricing in a high probability of further decline or stagnation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.16798675 |
| Address1 | 4,220 North Freeway |
| All Time High | 187.29 |
| All Time Low | 1.29 |
| Ask | 45.67 |
| Ask Size | 2 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 445,430 |
| Average Daily Volume3 Month | 661,734 |
| Average Volume | 661,734 |
| Average Volume10Days | 445,430 |
| Beta | 0.986 |
| Bid | 25.77 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 28.317 |
| City | Fort Worth |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 35.775 |
| Current Ratio | 1.644 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 36.23 |
| Day Low | 35.23 |
| Debt To Equity | 15.484 |
| Display Name | Omnicell |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,304,000 |
| Earnings Call Timestamp Start | 1,793,304,000 |
| Earnings Growth | 3.333 |
| Earnings Quarterly Growth | 3.307 |
| Earnings Timestamp | 1,793,277,000 |
| Earnings Timestamp End | 1,793,277,000 |
| Earnings Timestamp Start | 1,793,277,000 |
| Ebitda | 82,184,000 |
| Ebitda Margins | 0.06592 |
| Enterprise To Ebitda | 18.521 |
| Enterprise To Revenue | 1.221 |
| Enterprise Value | 1,522,141,696 |
| Eps Current Year | 2.26875 |
| Eps Forward | 2.055 |
| Eps Trailing Twelve Months | 0.82 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 34.6496 |
| Fifty Day Average Change | 1.1254005 |
| Fifty Day Average Change Percent | 0.032479465 |
| Fifty Two Week Change Percent | 16.798676 |
| Fifty Two Week High | 55.0 |
| Fifty Two Week High Change | -19.224998 |
| Fifty Two Week High Change Percent | -0.34954542 |
| Fifty Two Week Low | 29.09 |
| Fifty Two Week Low Change | 6.6850014 |
| Fifty Two Week Low Change Percent | 0.2298041 |
| Fifty Two Week Range | 29.09 - 55.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 997,363,800,000 |
| Float Shares | 44,378,721 |
| Forward Eps | 2.055 |
| Forward P E | 17.40876 |
| Free Cashflow | 134,181,872 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 3,485 |
| Fullday Change | 0.38500214 |
| Fullday Change Percent | 1.087884 |
| Fullday Price | 35.775 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.44014 |
| Gross Profits | 548,726,976 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.021459999 |
| Held Percent Institutions | 1.0842199 |
| Implied Shares Outstanding | 45,614,884 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. |
| Long Name | Omnicell, Inc. |
| Market | us_market |
| Market Cap | 1,631,872,512 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_32401 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 39,083,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,513,045,702 |
| Number Of Analyst Opinions | 7 |
| Open | 35.45 |
| Operating Cashflow | 181,435,008 |
| Operating Margins | 0.05909 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 15.4 |
| Phone | 877 415 9990 |
| Previous Close | 35.39 |
| Price Eps Current Year | 15.768596 |
| Price Hint | 2 |
| Price To Book | 1.2633754 |
| Price To Sales Trailing12 Months | 1.3089505 |
| Profit Margins | 0.03135 |
| Quick Ratio | 1.194 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.375 |
| Region | US |
| Regular Market Change | 0.38500214 |
| Regular Market Change Percent | 1.087884 |
| Regular Market Day High | 36.23 |
| Regular Market Day Low | 35.23 |
| Regular Market Day Range | 35.23 - 36.23 |
| Regular Market Open | 35.45 |
| Regular Market Previous Close | 35.39 |
| Regular Market Price | 35.775 |
| Regular Market Time | 1,792,079,026 |
| Regular Market Volume | 88,298 |
| Return On Assets | 0.0152199995 |
| Return On Equity | 0.03059 |
| Revenue Growth | 0.075 |
| Revenue Per Share | 27.489 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 45,614,884 |
| Shares Percent Shares Out | 0.0798 |
| Shares Short | 3,639,225 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 3,293,786 |
| Short Name | Omnicell, Inc. |
| Short Percent Of Float | 0.0968 |
| Short Ratio | 6.14 |
| Source Interval | 15 |
| State | TX |
| Symbol | OMCL |
| Target High Price | 70.0 |
| Target Low Price | 45.0 |
| Target Mean Price | 57.85714 |
| Target Median Price | 60.0 |
| Total Cash | 292,164,992 |
| Total Cash Per Share | 6.405 |
| Total Debt | 199,996,000 |
| Total Revenue | 1,246,702,976 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.82 |
| Trailing P E | 43.62805 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 39.73675 |
| Two Hundred Day Average Change | -3.96175 |
| Two Hundred Day Average Change Percent | -0.0996999 |
| Type Disp | Equity |
| Volume | 88,298 |
| Website | https://www.omnicell.com |
| Zip | 76,137 |